0001722820-18-000002.txt : 20181120 0001722820-18-000002.hdr.sgml : 20181120 20181120102131 ACCESSION NUMBER: 0001722820-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181120 DATE AS OF CHANGE: 20181120 EFFECTIVENESS DATE: 20181120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exonics Therapeutics, Inc. CENTRAL INDEX KEY: 0001722820 IRS NUMBER: 814846817 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-299113 FILM NUMBER: 181194578 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 781-749-3987 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 D/A 1 primary_doc.xml X0708 D/A LIVE 0001722820 Exonics Therapeutics, Inc. 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 781-749-3987 DELAWARE None None Corporation true 2016 John Ripple 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Executive Officer Director H. James Magee 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Executive Officer David Goeddel 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Director JeenJoo Kang 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Director Roger Perlmutter 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Director Jesper Gromada 490 Arsenal Way Suite 110 Watertown MA MASSACHUSETTS 02472 Executive Officer Biotechnology Decline to Disclose 06b true 0001722820-17-000001 2017-11-07 false true false 0 42043965 22043962 20000003 false 2 0 0 0 false Exonics Therapeutics, Inc. /s/ John Ripple John Ripple President and CEO 2018-11-17